Cargando…

Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder

PURPOSE: Non - muscle - invasive bladder cancer (NMIBC) can recur despite transurethral resection (TURBT) and adjuvant intravesical therapy. Tobacco products excreted in the urine are hypothesized to cause tumor - promoting effects on urothelial cells through direct contact. We determined if moderat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lunney, Austin, Haynes, Allan, Sharma, Pranav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541143/ https://www.ncbi.nlm.nih.gov/pubmed/30325609 http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0068

Ejemplares similares

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
por: Zhang, Shufang, et al.
Publicado: (2014)

Expression of Fibroblast Growth Factor Receptor 3 in the Recurrence of Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Maeng, Young-Hee, et al.
Publicado: (2010)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma
por: Tian, Zijian, et al.
Publicado: (2020)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
por: Basatac, Cem, et al.
Publicado: (2019)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021)

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2022)

Gastrocnemius acrometastasis from muscle-invasive urothelial bladder carcinoma: A case report
por: Roslly, Mohd Zulkimi, et al.
Publicado: (2021)

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
por: Tsamouri, Maria Malvina, et al.
Publicado: (2021)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Recurrence of Urothelial Bladder Carcinoma in the Colon Presenting as Hematochezia
por: El Douaihy, Youssef, et al.
Publicado: (2016)

Improvement of quality of life and symptom burden after robot-assisted radical prostatectomy in patients with moderate to severe LUTS
por: Leyh-Bannurah, Sami-Ramzi, et al.
Publicado: (2021)

Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate
por: Righetto, Marialaura, et al.
Publicado: (2021)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
por: Jin, Subin, et al.
Publicado: (2017)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder
por: Massari, Francesco, et al.
Publicado: (2015)

Non-invasive evaluation of lower urinary tract symptoms (LUTS) in men
por: Mangat, Reshma, et al.
Publicado: (2018)

Oxidative stress in the bladder of men with LUTS undergoing open prostatectomy: a pilot study
por: Averbeck, Marcio Augusto, et al.
Publicado: (2018)

Telocytes and ezrin expression in normal-appearing tissues adjacent to urothelial bladder carcinoma as predictors of invasiveness and recurrence
por: Wishahi, Mohamed, et al.
Publicado: (2023)

The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?
por: Digesu, Giuseppe Alessandro, et al.
Publicado: (2020)

Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis
por: Al-Maghrabi, Basim, et al.
Publicado: (2019)

Plasmacytoid urothelial carcinoma of the bladder with extensive scrotal wall invasion
por: Wang, Yong Gang, et al.
Publicado: (2016)

Status of Her2 over expression in muscle invasive urothelial bladder carcinoma: Report of 21 cases
por: Mejri, Nesrine, et al.
Publicado: (2014)

Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
por: Kang, Minyong, et al.
Publicado: (2015)

Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and Progression
por: Wishahi, Mohamed, et al.
Publicado: (2018)

IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype
por: Yang, Feiya, et al.
Publicado: (2019)

The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma
por: Shen, Haotian, et al.
Publicado: (2019)

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma
por: Feng, Yueyi, et al.
Publicado: (2019)

Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma
por: Kim, Bohyun, et al.
Publicado: (2021)

Mycotic Abdominal Aortic Aneurysm Secondary to BCG Therapy for Non-muscle Invasive Urothelial Carcinoma of the Bladder
por: Godard, Levi, et al.
Publicado: (2023)

SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
por: Lázaro, M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ovl71uuvhnguvplik7pka2kfvg